Early research (Phase 1)Looking for participantsNCT06977711
What this trial is testing
Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
Who this might be right for
Diffuse Large B-cell Lymphoma
The University of Texas Health Science Center at San Antonio 10